Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Detrusor External Sphincter Dyssynergia in Early SCI
NCT00711087Phase 2Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2007
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Detrusor external sphincter dyssynergia (DESD), neurogenic bladder dysfunction, sponsored by Baylor College of Medicine. Started Jul 2007; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
Detrusor external sphincter dyssynergia (DESD)neurogenic bladder dysfunction
Beyond the preview
Go deeper on NCT00711087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711087.